PerkinElmer (NYSE:PKI) inked a deal today to acquire Euroimmun Medical Laboratory Diagnostics for $1.3 billion in cash. The move is an effort to expand into autoimmune and allergy diagnostic markets, according to the scientific instruments-maker.
Germany-based Euroimmun has 2,400 employees and is expected to bring in $310 million in revenue this year.
Get the full story at our sister site, Drug Delivery Business News.